Xtent Sets Terms

Xtent Inc., a Menlo Park, Calif.-based developer of stent systems, has set its proposed IPO terms to 4.7 million common shares being offered at between $16 and $18 per share. It plans to trade on the Nasdaq under ticker symbol XTNT, with Piper Jaffray serving as lead underwriter. Xtent has raised around $75 million in total VC funding since its 2002 inception, including a $30 million Series D round last year at a post-money valuation of around $160 million. Backers include Morgenthaler Partners, Advanced Technology Ventures, Latterell Venture Partners and St. Paul Venture Capital. www.xtentinc.com